Norway· NO-ID_377A3DC0-32CD-4508-8515-2DF464A37F97
Paveron N
A papaverine product containing papaverine hydrochloride, registered in Norway by Linden. The same ATC class is registered in 9 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Papaverine is registered in 9 of 19 countries.
Countries holding a registration under ATC A03AD01 (papaverine), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 5 of them publish a price we can compare per daily dose
Papaverine · ATC A03AD01
9 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Japan
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Papaverine Hydrochloride
- Manufacturer
- Linden
- Country
- Norway (NO)
- ATC code
- A03AD01
- ATC class
- Papaverine
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_377A3DC0-32CD-4508-8515-2DF464A37F97
- no_varenummer28682910 x 2
- gtin4150027489909
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
281 interactions on record for papaverine.
Graded by severity as the source publishes them — 216 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Papaverine · interactions on record
281 records
- 216 severe
- 63 moderate
- 2 minor
Most severe, free to view
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- DolasetronA04AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Papaverine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomPapaverine 200mg/10ml solution for injection vialsSpecial Order
- United StatesPapaverine HydrochlorideNexus Pharmaceuticals, LLC
- BelgiumPapaverine HCl Sterop 100 mg/3 mlLaboratoires Sterop
- FinlandPapaverinOy Leiras Finland Ab
- FrancePAPAVERINE RENAUDIN 40 mg/ml, solution injectableLABORATOIRE RENAUDIN
- GermanyPaveron NLinden Arzneimittel-Vertrieb-Gmbh
- PolandPapaverinum hydrochloricum WZFZakłady Farmaceutyczne POLPHARMA S.A.
- CanadaPAPAVERINE HYDROCHLORIDE INJECTION USPSANDOZ CANADA INCORPORATED
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Belgium · Papaverine Hcl Sterop
- Bulgaria · Папаверин Актавис, Папаверин Софарма
- Germany · Paveron N
- Denmark · Papaverin Oba
- France · Papaverine Renaudin
- Italy · Papaverina Cloridrato Galenica Senese, Papaverina Cloridrato Monico
- Latvia · Papaverine Sopharma
- Poland · Papaverinum Hydrochloricum Wzf
- Portugal · Papaverina Labesfal
- Romania · Papaverina, Papaverină Arena
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d23ef2a5-aac2-4284-a2e8-8145702aab87 GET /v1/drugs/d23ef2a5-aac2-4284-a2e8-8145702aab87?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Injeksjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Papaverin",
"merkevare_id": "ID_377A3DC0-32CD-4508-8515-2DF464A37F97",
"name_form_strength": "Paveron N inj, oppl 25 mg/ml",
"prescription_group": "C"
}See everything about papaverine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.